MDxHealth (MDXH) Research & Development (2021 - 2025)
Historic Research & Development for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to -$2.0 million.
- MDxHealth's Research & Development rose 2558.4% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.8 million, marking a year-over-year increase of 4993.18%. This contributed to the annual value of -$16.8 million for FY2024, which is 63120.05% down from last year.
- According to the latest figures from Q3 2025, MDxHealth's Research & Development is -$2.0 million, which was up 2558.4% from $2.5 million recorded in Q2 2025.
- MDxHealth's 5-year Research & Development high stood at $2.5 million for Q2 2025, and its period low was -$3.6 billion during Q2 2022.
- Moreover, its 5-year median value for Research & Development was -$1.8 million (2023), whereas its average is -$212.3 million.
- In the last 5 years, MDxHealth's Research & Development plummeted by 12891.11% in 2023 and then skyrocketed by 18580.62% in 2025.
- Quarter analysis of 5 years shows MDxHealth's Research & Development stood at -$1.3 million in 2021, then soared by 36.69% to -$799000.0 in 2022, then tumbled by 128.91% to -$1.8 million in 2023, then plummeted by 52.43% to -$2.8 million in 2024, then increased by 28.01% to -$2.0 million in 2025.
- Its last three reported values are -$2.0 million in Q3 2025, $2.5 million for Q2 2025, and -$2.5 million during Q1 2025.